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(rAN) translation resulting in the production of three aggre-
gation-prone proteins. The goal of this study was to exam-
ine whether antisense transcripts resulting from bidirectional 
transcription of the expanded repeat behave in a similar 
manner. We show that ectopic expression of (CCCCgg)66 
in cultured cells results in foci formation. Using novel poly-
clonal antibodies for the detection of possible (CCCCgg)exp 
rAN proteins [poly(Pr), poly(gP) and poly(PA)], we vali-
dated that (CCCCgg)66 is also subject to rAN translation 
in transfected cells. Of importance, foci composed of anti-
sense transcripts are observed in the frontal cortex, spinal 
cord and cerebellum of c9FTD/AlS cases, and neuronal 
inclusions of poly(Pr), poly(gP) and poly(PA) are present 
in various brain tissues in c9FTD/AlS, but not in other neu-
rodegenerative diseases, including CAg repeat disorders. 
Of note, rNA foci and poly(gP) inclusions infrequently co-
occur in the same cell, suggesting these events represent two 
distinct ways in which the C9ORF72 repeat expansion may 
evoke neurotoxic effects. These findings provide mechanistic 
insight into the pathogenesis of c9FTD/AlS, and have sig-
nificant implications for therapeutic strategies.
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Introduction
An expanded ggggCC hexanucleotide repeat within a 
non-coding region of the C9ORF72 gene is the most com-
mon genetic cause of frontotemporal dementia (FTD) 
and amyotrophic lateral sclerosis (AlS), two devastating 
multisystem neurodegenerative disorders with significant 
Abstract Frontotemporal dementia (FTD) and amyo-
trophic lateral sclerosis (AlS) are devastating neurodegener-
ative disorders with clinical, genetic, and neuropathological 
overlap. A hexanucleotide (ggggCC) repeat expansion in a 
non-coding region of C9ORF72 is the major genetic cause of 
both diseases. The mechanisms by which this repeat expan-
sion causes “c9FTD/AlS” are not definitively known, but 
rNA-mediated toxicity is a likely culprit. rNA transcripts 
of the expanded ggggCC repeat form nuclear foci in 
c9FTD/AlS, and also undergo repeat-associated non-ATg 
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genetic, neuropathological, and clinical overlap [11, 30]. 
FTD, a common form of early-onset dementia, is character-
ized clinically by abnormalities in behavior and language, 
whereas AlS is characterized by upper and lower motor 
neuron signs, which include weakness and muscle atrophy. 
FTD-like cognitive and behavioral impairments are also 
present in up to 50 % of AlS patients [16, 19, 27], and as 
many as half of FTD patients develop motor neuron dys-
function (MND) reminiscent of AlS [19].
The mechanisms by which the C9ORF72 hexanucleo-
tide repeat expansion causes “c9FTD/AlS” are not defini-
tively known, but at least three pathogenic pathways may 
be at play. Several groups have shown that mrNA levels 
of certain C9ORF72 variants are decreased in c9FTD/AlS 
[11, 15, 25, 30], suggesting loss of C9OrF72 function as 
a potential neurotoxic mechanism. In addition, rNA tran-
scripts containing the expanded repeat may cause neuro-
degeneration by two means: through their accumulation 
into discrete structures in the nucleus, termed rNA foci, 
and by serving as a template for the synthesis of aberrantly 
expressed, aggregation-prone proteins by repeat-associated 
non-ATg (rAN) translation. Indeed, (ggggCC)exp rNA 
foci are observed in c9FTD/AlS [11], and the accumula-
tion of neuronal inclusions composed of “c9rAN proteins” 
is a pathological hallmark of c9FTD/AlS [3, 25].
rNA foci are thought to cause cellular toxicity by seques-
tering specific rNA-binding proteins in a sequence-depend-
ent manner, consequently disrupting their function [4]. In 
myotonic dystrophy type 1 (DM1), for instance, rNA foci 
formed of CAg·CTg repeat transcripts bind and inactivate 
the splicing factor muscleblind-like 1 protein (MBNl1) [23, 
32, 33]. This sequestration of MBNl1 results in the mis-
splicing of a subset of pre-mrNA targets that account for 
some of the characteristic features of disease [10, 20]. Tran-
scripts of (ggggCC)exp that accumulate as nuclear foci in 
c9FTD/AlS may similarly sequester rNA-binding proteins 
and cause the misregulation of crucial downstream rNA 
targets leading to cellular dysfunction [24, 29, 38].
In addition to foci formation, transcripts of expanded 
repeats may be susceptible to rAN translation, an uncon-
ventional mode of translation that occurs across expanded 
repeat tracts despite the absence of an initiating codon. 
First described by ranum and colleagues for expanded tri-
nucleotide CAg·CTg repeats [39], transcripts of expanded 
Cgg repeats [34], and the aforementioned ggggCC 
repeats [3, 25] are now known to be rAN translated. 
Because rAN translation can occur in all possible reading 
frames, various products can be synthesized from a given 
transcript. recently, we, as well as the edbauer group and 
colleagues, independently reported that rAN translation of 
(ggggCC)exp rNA in c9FTD/AlS results in the produc-
tion of poly(gP), poly(gA), and poly(gr) proteins [3, 25]. 
The presence of neuronal inclusions composed of these 
c9rAN proteins throughout the central nervous system is 
now considered pathognomonic of c9FTD/AlS [3, 25].
For many microsatellite expansion disorders, the 
expanded repeat is bidirectionally transcribed [4]. Detect-
able expression of both sense and antisense transcripts 
containing the hexanucleotide repeat in C9ORF72 
patients indicates that bidirectional transcription also 
occurs in c9FTD/AlS [25]. Consequently, not only do 
(ggggCC)exp transcripts form foci and undergo rAN 
translation, so too may (CCCCgg)exp transcripts resulting 
from bidirectional transcription of the C9ORF72 expanded 
repeat. The goal of this study was thus to examine whether 
(CCCCgg)exp-derived rNA foci and c9rAN translation 
proteins are present in c9FTD/AlS.
Materials and methods
Secondary structure prediction and model building 
of CCCCgg repeats
Folding of the rNA sequence comprising CCCCgg 
repeats of 10 (60 bases), 50 (300 bases), and 200 (1,200 
bases) was carried out as previously described to deter-
mine secondary structure motifs [3]. The secondary struc-
ture prediction and modeling was built by examining the 
output from several rNA prediction packages: MFOlD, 
Sfold, Vienna rNA Package (rNAfold) [12, 17, 18, 21, 
22, 31, 40, 41]. MFOlD utilizes a minimum free energy 
rNA structure prediction algorithm, Sfold utilizes statisti-
cal sampling of all possible structures, while Vienna Pack-
age has several options, including an minimum free energy 
calculation. equivalent structures were given from each 
package for the ten repeat cases. MFOlD was used as the 
primary secondary structure prediction package for consist-
ency across all models. Free energies were calculated for 
each secondary structure prediction at the level of decom-
position (base pairing) and global energy [36]. MFOlD 
verifies each secondary structure prediction generated for 
valid structure [36]. MFOlD parameters include the fol-
lowing: (1) linear rNA sequence; (2) zero constraints, 
forces, or prohibitions on all bases allowing maximal sam-
pling; (3) folding temperature of 37 °C; (4) physiological 
ionic conditions; (5) structure draw mode: untangle with 
loop fix; and (6) the remainder of MFOlD settings were 
set to default.
generation of antibodies
For each of the peptide antigens (C-Ahx-(Pr)8-amide, 
C-Ahx-(gP)8-amide and C-Ahx-(PA)8-amide), two rabbits 
were immunized. Pre-immune serum from each rabbit was 
tested against peptide antigens and tissue from c9FTD/AlS 
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cases by Western blot and immunohistochemistry, respec-
tively, and confirmed negative. Antiserum was used directly 
or affinity purified before use.
Meso Scale Discovery immunoassays
Peptides diluted in Tris-buffered saline (TBS) were added 
to duplicate wells (35 μl/well) of a 96-well MSD assay 
plate at final concentrations 0.1 μg/well. Following over-
night incubation at 4 °C, wells were washed with TBS 
containing 0.2 % Tween 20 (TBSTw), and blocked with 
TBSTw+3 % non-fat milk. Antibody solution (25 μl/well) 
containing the indicated anti-Pr, anti-gP, anti-PA, anti-
gA or anti-gr antibodies (1:1,000) and SUlFO-TAg™-
rabbit secondary antibody (0.5 μg/ml, in blocking buffer) 
was added. Following a 2-h incubation and final washes, 
antibody binding to immobilized peptides was evaluated by 
adding MSD read Buffer and measuring light emission at 
620 nm upon electrochemical stimulation using the MSD 
Sector Imager 2400.
Western blot analysis and immunofluorescence staining 
for antibody characterization
HeK293T cells were transfected with lipofectamine™ 
2000 with pegFP-C1 vector only, or pegFP-C1 (Clon-
tech) plasmids into which oligonucleotides of five repeats 
of Pr, gP, PA, gA or gr were inserted. For Western blot-
ting, cell lysates collected 2 days post-transfection were 
resolved by 10 % Tris–glycine SDS-PAge (Invitrogen) 
and transferred to nitrocellulose membranes for probing 
with anti-Pr, anti-gP, anti-PA, anti-gA or anti-gr, or with 
anti-gFP (Abcam, 1:2,000). For immunostaining, cover-
slips were fixed, permeabilized and blocked, then probed 
with the indicated antibodies followed by anti-rabbit-
AF594 (Alexa Fluor) and Hoechst [3].
Cloning of CCCCgg expression vectors
To generate the antisense (CCCCgg)2 and (CCCCgg)66 
expression vectors, we first generated sense (ggggCC)2 
and (ggggCC)66 expression vectors. Toward this end, 
genomic DNA from muscle or spleen from a C9ORF72 
expanded repeat carrier was used as a template in a nested 
PCr strategy using ThermalAce DNA Polymerase (Invit-
rogen) to amplify the (ggggCC)n repeat region, includ-
ing 113 bp of 5′ and 99 bp of 3′ flanking sequence. The 
upstream primer used was 5′-AAggAAgCTTAg-
TACTCgCTgAgggTgAAC-3′; downstream primers 
used were 5′-gCTTggATCCCCCACTCgCCACCgC-
CTg-3′ and 5′-gTCAgAgAAATgAgAgggAAAg-3′. 
The PCr products were cloned into the pAg3 expression 
vector (kindly provided by Dr. T. golde, University of 
Florida) using restriction sites HindIII and BamHI. The 
pAg3 expression vector has a pcDNA3.0 backbone and 
a CMV-enhanced chicken B-actin promoter. The clones 
containing (ggggCC)2 or (ggggCC)66 were screened 
by colony PCr, and further verified by hairpin sequence 
analysis. The plasmids of (ggggCC)2 or (ggggCC)66 
were digested using HindIII, and then the overhangs 
were filled-in using DNA Polymerase I (Klenow) Frag-
ment. After purification, the fragments were digested with 
BamHI. The inserts with (ggggCC)2 or (ggggCC)66, 
including the 5′ and 3′ flanking sequences, were re-cloned 
in the antisense orientation into a pAg3 expression vec-
tor using BamHI and ecorV to generate the (CCCCgg)2 
and (CCCCgg)66 expression constructs. The sequence of 
antisense vectors was verified by hairpin sequence analy-
sis. Note that the DNA sequence of the CCCCgg repeat is 
provided in Online resource 1, which also highlights the 
regions included in the generation of pAg3-(CCCCgg)2 
and pAg3-(CCCCgg)66 expression vectors.
rNA fluorescence in situ hybridization of cultured cells 
expressing (CCCCgg)n expression vectors
evaluation of foci formation in Hela cells transfected with 
(CCCCgg)2 or (CCCCgg)66 expression vectors was car-
ried out by rNA fluorescence in situ hybridization (FISH). 
In brief, cells grown on glass coverslips were transfected 
with 0.5 μg of the (CCCCgg)2 or (CCCCgg)66 con-
structs. After 36 h, cells were fixed and permeabilized in 
4 % paraformaldehyde + 20 % acetic acid + 2 mM ribonu-
cleoside vanadyl complex (Sigma) for 10 min at room tem-
perature. Cells were then washed with phosphate buffered 
saline treated with diethylpyrocarbonate (DePC–PBS), and 
hybridized with denatured Cy3-conjugated (ggggCC)4 
probe (2 ng/μl) in hybridization buffer (50 % formamide, 
10 % dextran sulfate, 0.1 mg/ml yeast trNA, 2X saline–
sodium citrate buffer (SSC), 50 mM sodium phosphate 
buffer) overnight at 37 °C. After washing once with 40 % 
formamide/1XSSC for 30 min at 37 °C, and twice with 
DePC–PBS for 5 min at room temperature, nuclei were 
counterstained with Hoechst 33258 (1 μg/ml, Invitrogen) 
prior to mounting coverslips. Images were obtained on a 
Zeiss lSM 510 MeTA confocal microscope.
Western blot analysis of cultured cells expressing 
(CCCCgg)n expression vectors
To determine whether ectopic expression of expanded CCC-
Cgg transcripts leads to rAN translation, HeK293T cells 
were transfected with 5 μg of the (CCCCgg)2 or (CCC-
Cgg)66 constructs. After 36 h, cells were harvested and 
washed with ice-cold PBS (pH 7.4), then cell pellets were 
lysed in buffer (50 mM Tris–HCl, pH 7.4, 300 mM NaCl, 
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1 % Triton-X-100, 5 mM eDTA, 2 % sodium dodecyl sul-
fate (SDS), plus phenylmethylsulfonyl fluoride (PMSF) and 
both a protease and phosphatase inhibitor mixture). After 
centrifugation at 16,000g for 20 min at 4 °C, the supernatant 
was collected and protein concentration determined by BCA 
assay. For Western blot analysis, samples were prepared 
in laemmli’s buffer, heated for 5 min at 95 °C, and equal 
amounts of protein (30 μg) were loaded into Novex® 10–
20 % Tricine gels. After transfer, blots were blocked with 
5 % non-fat dry milk in TBST for 1 h, and then incubated 
with the purified anti-Pr, anti-gP or anti-PA (1:1,000), or 
mouse monoclonal gAPDH antibody (1:10,000, Biodesign) 
overnight at 4 °C. Membranes were washed then incubated 
with anti-species horseradish peroxidase-linked second-
ary antibodies (1:5,000; Jackson Immunoresearch) for 1 h. 
Protein expression was visualized by enhanced chemilumi-
nescence treatment and exposure to film.
Human case material
All cases examined in this study were selected from 
a series of autopsied brains submitted to the neuropa-
thology laboratory at Mayo Clinic in Jacksonville. The 
sources of this case material include the Mayo Clinic 
Florida AlS Center (n = 11), referral to the Parkinson 
disease brain bank (n = 7), the State of Florida Alzhei-
mer’s Disease Initiative (n = 2), Florida Alzheimer’s Dis-
ease research Center (n = 1) and CurePSP/Society of 
Progressive Supranuclear Palsy brain bank (n = 1). The 
presence or absence of C9ORF72 repeat expansion was 
determined using frozen cerebellar tissue from the right 
hemibrain and a previously described repeat-primed pol-
ymerase chain reaction (PCr) method [11]. In addition, 
repeat length was estimated using Southern blotting tech-
niques as previously described [35] (Table 1). In brief, 
7–10 μg of high-quality genomic DNA extracted from 
frozen frontal cortex and cerebellum was digested with 
XbaI, and electrophoresed in a 0.8 % agarose gel. DNA 
was then transferred to a positively charged nylon mem-
brane (roche), cross-linked, and subsequently hybridized 
with a DIg-labeled probe. expansions were visualized 
with anti-DIg antibody (roche) and CDP-star substrate 
(roche) on X-ray film after multiple exposures. The most 
abundant expansion sizes were estimated using Alphae-
aseFC (Alpha Innotech) based on their position relative to 
DNA molecular weight markers.
Table 1  C9ORF72 antisense transcript rAN translation cohort
− absent, ± sparse (<5 inclusions), + mild, ++ moderate, +++ severe






Sex repeat size Hippocampal burden Cerebellar burden
Frontal cortex Cerebellum PA Pr gP PA Pr gP
1 Y FTlD-TDP 66 M 16.0 12.5 ± + +++ ± + +++
2 Y FTlD-TDP 71 M 25.2 11.4 ± ± ++ ± ± ++
3 Y FTlD-TDP 86 M 50.0 17.5 + ± +++ ± ± +++
4 Y FTlD-MND 68 M 25.6 12.8 ± ± ++ ± ± +++
5 Y FTlD-MND 70 M 38.4 10.1 + + +++ + + +++
6 Y FTlD-MND 61 F 35.6 13.7 + + +++ ± ± +++
7 Y AlS 53 M 46.8 14.9 + + +++ + + +++
8 Y AlS 49 F 23.8 10.0 + + +++ ± ± +++
9 Y AlS 41 F 22.3 10.9 + + +++ + + +++
10 N FTlD-TDP 88 F − − − − − − − −
11 N FTlD-TDP 65 M − − − − − − − −
12 N FTlD-TDP 83 F − − − − − − − −
13 N FTlD-MND 64 M − − − − − − − −
14 N FTlD-MND 72 F − − − − − − − −
15 N FTlD-MND 66 F − − − − − − − −
16 N AlS 60 M − − − − − − − −
17 N AlS 61 F − − − − − − − −
18 N AlS 53 F − − − − − − − −
19 N HD 80 F − − − − − − − −
20 N HD 70 F − − − − − − − −
21 N Kennedy’s 80 M − − − − − − − −
22 N SCA3 53 M − − − − − − − −
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Fluorescence in situ hybridization and immunofluorescence 
staining of human tissue
Formalin-fixed, paraffin-embedded frontal cortex, spinal 
cord, and cerebellum sections were cut at a 5-μm thick-
ness and mounted on glass slides, then subjected to rNA 
FISH followed by immunofluorescence staining. For 
FISH, slides were deparaffinized and rehydrated, incu-
bated with pepsin (4 mg/ml in 0.9 % NaCl, pH 1.5) for 
20 min at 37 °C, rinsed in water, then immersed in ice-
cold 20 % acetic acid for 90 s, prior to dehydration. A 
Cy3-tagged (ggggCC)4 probe (IDT) which hybridizes 
to the expanded CCCCgg repeat was applied to the tis-
sue, which was then sealed under a coverslip. Prior to use, 
the probe was diluted to 5 ng/μl in hybridization buffer 
(10 % dextran sulfate, 50 % formamide, 2XSSC, 50 mM 
sodium phosphate buffer, 10 ng/ml trNA pH 7.0), then 
heated at 80 °C for 10 min, placed on ice for 5 min, then 
heated at 37 °C for 10 min. Alternatively, to detect foci 
formed of (ggggCC)exp rNA, a TYe563-labeled lNA 
probe (5′TYe563-CCCggCCCCggCCCC-3′TYe563; 
exiqon, Inc) was applied to the tissue. This probe was 
diluted to 0.4 ng/ml in hybridization buffer (10 % dextran 
sulfate, 50 % formamide, 2XSSC, 50 mM sodium phos-
phate buffer, 10 ng/ml trNA, pH 7.0), then heated at 80 °C 
for 75 s, according the manufacturer’s instructions. Follow-
ing a 2-day hybridization at 37 or 55 °C for the antisense 
and sense probe, respectively, coverslips were removed and 
slides were washed: once in 2X SSC, three times in 50 % 
formamide/2X SCC at 37 °C, and three times in 1X SSC 
at 37 °C. Slides were subsequently subjected to immuno-
fluorescence staining: slides were blocked with DAKO 
Serum-Free Protein Block and then incubated with anti-gP 
(1:3,000), choline acetyltransferase antibody (ChAT; 1:200; 
Chemicon AB144P), microtubule-associated protein 2 anti-
body (MAP2; 1:750, clone AP-20) or glial fibrillary acidic 
protein antibody (gFAP; 1:500, clone gA-5) overnight 
at 4 °C. The following day, slides were incubated with an 
Alexa Fluor 488-conjugated secondary antibody (1:500, 
Molecular Probes) for 1.5 h at room temperature. Slides 
were then treated with a solution of Sudan Black for 2 min 
to block auto-fluorescence, and coverslipped using Vectash-
ield-DAPI mounting medium (Vector laboratories).
Imaging was performed using a Zeiss Axio Imager Z1 
microscope to visualize foci and poly(gP) inclusions. 
Although it is difficult to distinguish binding of the probe 
to an individual rNA transcript given that the fluorescence 
resulting thereof is not sufficiently strong to yield a sig-
nal above background, the FISH method employed is well 
suited to examine nuclear foci. The presence of multiple 
labeled transcripts in a compact location, as is the case for 
foci, results in a highly distinct, punctate fluorescent sig-
nal much brighter than background. Note that, to validate 
specificity of the probes targeting ggggCC and CCC-
Cgg rNA, FISH was carried out on frontal cortex and cer-
ebellar tissue from AlS, frontotemporal lobar degeneration 
(FTlD), and FTlD-MND patients with normal C9ORF72 
repeat length. In addition, a (CAgg)6 probe targeting the 
CCTg repeat was tested and shown also to be negative.
To determine what percentage of affected cells (i.e., 
cells having either foci or a poly(gP) inclusion) have both 
nuclear foci and poly(gP) pathology, we analyzed frontal 
cortex and cerebellar sections of four c9FTD/AlS cases 
co-stained for either sense or antisense foci and poly(gP) 
inclusions. For each section, we examined 25 cells with 
inclusions by fluorescence microscopy, and then changed 
the excitation filter to determine whether they also had 
foci; we then examined 25 cells with foci and determined 
whether they had inclusions. In this manner, a total of 50 
cells were examined per section. For each group (group 
1—frontal cortex probed for antisense foci and poly(gP) 
inclusions; group 2—cerebellum probed for antisense foci 
and poly(gP) inclusions; group 3—frontal cortex probed 
for sense foci and poly(gP) inclusions; group 4—cerebel-
lum probed for sense foci and poly(gP) inclusions), the 
percentage of cells having both foci and inclusions was cal-
culated and compared by two-way ANOVA. In addition, we 
compared the frequency of sense and antisense foci in the 
frontal cortex of the four examined cases. For each section, 
the number of cells with foci and the number of total cells 
were counted in 12 randomly selected, non-overlapping 
fields from layers I–III. The average percentage of cells 
with antisense foci among the four cases was compared to 
the average percentage of cells with sense foci by paired, 
two-tailed t test.
Immunohistochemistry
For immunohistochemical analysis, 9 cases exhibiting an 
expanded C9ORF72 repeat (3 FTlD-TDP, 3 FTlD-MND, 
3 AlS) were matched with 13 negative control cases that 
lacked the expanded repeat, including 3 FTlD-TDP, 3 
FTlD-MND, 3 AlS, and 4 cases with CAg repeat disor-
ders, including 2 cases with Huntington’s disease, 1 case 
with Kennedy’s disease, and 1 case with spinocerebellar 
ataxia type 3 (Table 1). For the 9 c9FTD/AlS cases and 
the 9 FTD/AlS matched controls, immunohistochemistry 
was performed on formalin-fixed paraffin-embedded tissue 
from the motor cortex, hippocampus (including temporal 
cortex), basal forebrain (including amygdala), thalamus (at 
the level of the subthalamic nucleus), medulla, and cerebel-
lum. For the four trinucleotide repeat disorders, sections 
from the basal forebrain (2 Huntington’s disease cases), 
medulla (Kennedy’s disease case) or pons (spinocerebellar 
ataxia type 3 case) were used. Five-micron-thick tissue sec-
tions were cut from paraffin blocks, mounted on charged 
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glass slides, and allowed to dry overnight at 65 °C. The 
following day, slides were deparaffinized and rehydrated 
in serial washes in xylene and alcohol before steaming the 
slides for 30 min in 1X Tris–eDTA (pH 9) buffer solution. 
Immunohistochemistry was performed using the Dako 
Autostainer and the Dako enVision™ + rabbit (DAB) 
kits. Immunostaining was performed with the following 
antibodies: anti-PA (rb8604, 1:2,500), anti-gP (rb7379, 
1:10,000), and anti-Pr (rb8736, affinity purified, 1:100). 
Following immunohistochemistry, slides were counter-
stained with lerner’s hematoxylin, dehydrated, and cover-
slipped. All imaging was conducted using the Zeiss Axio 
Imager Z1 microscope.
Results
Characterization of antibodies for the detection of c9rAN 
proteins produced by rAN translation of (CCCCgg)exp 
rNA
The rNA structure of expanded repeats is believed to 
influence their susceptibility to rAN translation [9, 39]. 
We had previously reported that (ggggCC)exp rNA is 
predicted to form imperfect hairpins and is rAN trans-
lated [3]. Using methodologies for generating second-
ary structure predictions, we thus sought to determine 
whether (CCCCgg)exp rNA is predicted to have a simi-
lar structure and also be prone to rAN translation. It 
should be noted that, while the reverse complement of 
the 5′-ggggCC-3′ repeat is 5′-ggCCCC-3′, there are 
4 gs downstream of the last sense ggggCC repeat, 
thus making the first antisense repeat CCCCgg (Fig. 1, 
Online resource 1). The major rNA secondary struc-
ture prediction for 10 antisense CCCCgg repeats or 10 
sense ggggCC repeats is stable imperfect hairpins, 
but the ggggCC repeat structure has a lower compos-
ite global energy (ΔG = −40.8 kcal/mol), and therefore 
greater stability, than the antisense CCCCgg repeats 
(ΔG = −35.3 kcal/mol) (Online resource 2). Nonethe-
less, both ggggCC and CCCCgg repeats become suc-
cessively more stable as repeat length increases (Online 
resource 2b). given these observations, the CCCCgg 
repeat, like its ggggCC counterpart, may be rAN trans-
lated. To determine whether this is indeed the case, two 
independent rabbit polyclonal antibodies were gener-
ated against each of the products that could be produced 
from rAN translation of (CCCCgg)exp transcripts in the 
three alternate reading frames: poly(Pr), poly(Pg), and 
poly(PA) (Fig. 1). given that poly(Pg) [aka poly(gP)] 
proteins can be translated from both sense and antisense 
transcripts of the C9ORF72 repeat expansion (Fig. 1), 
“gP” is henceforth used when referring to these proteins.
Specificity of anti-Pr, anti-gP and anti-PA antibod-
ies toward their respective antigen was evaluated by 
quantitative electrochemiluminescent immunoassays. 
Measurement of antibody binding to immobilized (Pr)8, 
(gP)8 or (PA)8 peptides showed that all antibodies bound 
only their respective antigen (Fig. 2a). Consistent with 
these findings, anti-Pr, anti-gP and anti-PA antibodies 
respectively detected exogenously expressed enhanced 
gFP-tagged (Pr)5, (gP)5 or (PA)5 in HeK293T cells, 
as assessed by Western blot of cell lysates (Fig. 2b), and 
immunofluorescence staining of cells (Fig. 2c). Anti-
Pr, -gP and -PA antibodies were additionally tested 
against poly(gA) and poly(gr) peptides, which rep-
resent c9rAN proteins produced from the sense tran-
script (Fig. 1). All antibodies but one detected only their 
respective antigen, as assessed by immunoassay, Western 
blot and immunofluorescence staining of cultured cells 
(Online resource 3). Anti-Pr (7378), however, did show 
modest cross-reactivity with the gr peptide by immu-
noassay, but such cross-reactivity was not observed by 
Western blot or immunofluorescence staining (Online 
resource 3).
exogenous (CCCCgg)exp transcripts are subject  
to rAN translation in cultured cells
Having confirmed specificity of these novel antibod-
ies toward potential (CCCCgg)n c9rAN proteins, they 
were then used to evaluate whether poly(Pr), poly(gP) 
or poly(PA) proteins can indeed be rAN translated from 
expanded CCCCgg repeats. To address this question, a 
(CCCCgg)66 expression vector having no initiating ATg 
start codon upstream of the repeats was generated for the 
transfection of cultured cells. As shown in Fig. 3a, expres-
sion of (CCCCgg)66, but not of non-expanded (CCC-
Cgg)2, led to the formation of nuclear foci, as assessed 
by rNA FISH using a Cy3-tagged (ggggCC)4 probe 
targeting the CCCCgg repeat. ectopic expression of 
(CCCCgg)66 also resulted in the synthesis of poly(gP) 
Fig. 1  Schematic representation of the possible proteins generated 
by rAN translation of expanded ggggCC and CCCCgg repeats in 
all possible reading frames
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and poly(Pr) proteins, but not poly(PA), as assessed by 
Western blot of cell lysates (Fig. 3b). These c9rAN pro-
teins were not observed in cells expressing (CCCCgg)2 
suggesting that their formation is repeat length-dependent 
(Fig. 3b).
Nuclear foci of (CCCCgg)exp transcripts are present 
in brain and spinal cord of c9FTD/AlS patients
It was previously shown that transcripts of the expanded 
ggggCC repeat accumulate as nuclear rNA foci in the 
frontal cortex and spinal cord of c9FTD/AlS patients 
[11]. To determine whether expression of antisense tran-
scripts of (CCCCgg)exp similarly result in foci forma-
tion in human tissue, FISH was performed on paraffin-
embedded frontal cortex and spinal cord sections from 
c9AlS, c9FTlD or c9FTlD-MND patients using the 
Cy3-(ggggCC)4 probe, the specificity of which was 
verified using sections from affected patients with normal 
C9ORF72 repeat lengths. Cells harboring (CCCCgg)exp 
nuclear foci were observed throughout all layers of the 
frontal cortex, as well as in the white matter, of c9AlS, 
Fig. 2  Antibody characteriza-
tion for c9rAN proteins. a The 
immunoreactivity of antibodies 
to c9rAN proteins towards 
(PA)8, (Pr)8 and (gP)8 peptides 
was measured by adsorbing 
peptides onto carbon electrodes 
in 96-well MSD plates, and co-
incubating wells with anti-PA, 
anti-Pr or anti-gP antibodies, 
and a SUlFO-tagged anti-rabbit 
secondary antibody. Antibody 
binding to respective peptides 
was quantified by measuring the 
intensity of emitted light upon 
electrochemical stimulation of 
the plate using the MSD Sector 
Imager 2400. For each pair of 
antibodies, binding responses 
were normalized to the signal of 
the antibody showing the high-
est binding to its respective anti-
gen. Error bars indicate stand-
ard deviations from duplicate 
wells. b Western blot analysis 
of lysates from HeK293T cells 
transfected to express enhanced 
gFP-tagged (PA)5, (Pr)5 or 
(gP)5. Blots were probed with 
the indicated antibodies. c 
Immunofluorescence staining of 
HeK293T cells transfected to 
express the indicated enhanced 
gFP (green)-tagged peptides 
using anti-PA, anti-Pr or anti-
gP (red) antibodies. Nuclei are 
stained with Hoechst (blue). 
Scale bar 10 μm. Note that 
similar studies were conducted 
to test potential cross-reactivity 
of antibodies to poly(gA) and 
poly(gr), as shown in Online 
resource 3
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c9FTlD and c9FTlD-MND patients, with the number of 
foci in affected cells ranging from few (e.g., 1–2) to many 
(>10), and with the size of foci being variable (Fig. 4a). 
likewise, (CCCCgg)exp nuclear foci were present in cells 
of the spinal cord, including ChAT-immunopositive motor 
neurons (Fig. 4b).
Compared to FTD and AlS cases lacking the 
C9ORF72 expansion, c9FTD/AlS is marked by abnor-
mal cerebellar pathology, such as inclusions composed 
of (ggggCC)exp rAN proteins [3, 25], as well as inclu-
sions negative for TDP-43, but immunopositive for p62, 
ubiquitin, and various ubiquitin-binding proteins [1, 28]. 
Therefore, we evaluated whether (CCCCgg)exp rNA 
foci, as well as (ggggCC)exp rNA foci, are present 
in the cerebellum of C9ORF72 expanded repeat carri-
ers. Multiple cells with rNA foci composed of sense or 
antisense transcripts were detected, and these were most 
often observed in proximity to the Purkinje cell layer 
separating the granular and molecular layers (Fig. 4c). 
Foci were also occasionally present in cells of the molec-
ular layer, deep within the granular layer, in Purkinje 
cells, and in cells within the white matter (Fig. 4c). Post-
FISH immunofluorescent staining with MAP2, a neu-
ron marker, and gFAP, an astrocyte marker, confirmed 
that nuclear foci were present in both cell populations 
(Fig. 5). These findings indicate that, in addition to the 
frontal cortex and spinal cord, rNA foci resulting from 
the hexanucleotide repeat expansion in C9ORF72 accu-
mulate in the cerebellum.
Inclusions of (CCCCgg)exp c9rAN proteins are present 
in c9FTD/AlS
Next, the presence of c9rAN proteins synthesized from 
the antisense repeat was analyzed in human brain tissue. 
Immunohistochemistry with the anti-PA and anti-Pr anti-
bodies revealed sparse neuronal cytoplasmic inclusions in 
all sections examined from the nine c9FTD/AlS cases. 
lesion burden was greatest in the hippocampus (dentate 
fascia and hippocampus proper), lesser in the motor cortex, 
temporal cortex, amygdala, as well as thalamus, and low-
est in the cerebellum and medulla (Fig. 6). Many of the 
lesions were of the characteristic “star-shaped” morphol-
ogy. Immunohistochemistry with the anti-gP antibody 
revealed abundant pathology in all regions that paralleled 
the pathologic burden and distribution previously described 
with C9rANT antibodies [3]. Semi-quantitative analysis 
of anti-gP, anti-PA or anti-Pr immunoreactive-inclusion 
burden in the hippocampus and cerebellum is shown in 
Table 1. Neuronal c9rAN protein inclusions were not seen 
in the nine FTD/AlS matched control cases, or in the four 
trinucleotide repeat disorder cases.
rNA foci and poly(gP)-inclusions infrequently coexist 
in the same cell
The findings above, together with previous studies [2, 3, 11, 
25], establish that (ggggCC)exp and (CCCCgg)exp tran-
scripts form nuclear rNA foci and undergo rAN transla-
tion; nonetheless, the relationship between these two events 
remains unclear. The presence of foci could be indicative 
of high levels of (ggggCC)exp and (CCCCgg)exp tran-
scripts, thus increasing the possibility of rAN translation. 
Conversely, the formation of nuclear foci may seques-
ter these transcripts away from translational machinery, 
thus decreasing the likelihood of rAN translation. given 
that both foci formation and rAN translation are poten-
tially pathogenic, we examined the relationship between 
foci and inclusions composed of poly(gP), which is rAN 
translated from both sense and antisense transcripts. To this 
end, sections of cerebellar and frontal cortex from c9AlS, 
c9FTlD and c9FTlD-MND patients were subjected to 
FISH for the detection of (CCCCgg)exp or ggggCCexp 
rNA foci, followed by immunofluorescence staining for 
poly(gP). remarkably, while foci and anti-(gP)-immuno-
reactive inclusions were occasionally present in the same 
cell, the majority of affected cells had only rNA foci or 
only poly(gP) inclusions (Fig. 7a, b). To determine what 
percentage of cells have both foci and poly(gP) inclusions 
in the frontal cortex and cerebellum, quantitative analy-
sis was undertaken on four cases co-stained for poly(gP) 
inclusions and either sense or antisense foci. For each sec-
tion, we examined 25 cells with inclusions and determined 
Fig. 3  expression of expanded CCCCgg repeats in cultured 
cells leads to foci formation and expression of c9rAN proteins. a 
HeK293T cells transfected to express (CCCCgg)2 or (CCCCgg)66 
were subjected to rNA fluorescence in situ hybridization using a 
probe against CCCCgg repeat transcripts. Note the foci (red) in 
Hoechst-stained nuclei (blue) of (CCCCgg)66-expressing cells, 
but not (CCCCgg)2-expressing cells. Scale bar 5 μm. b Western 
blot analysis of lysates from (CCCCgg)n-expressing cells shows 
that poly(Pr) and poly(gP) proteins, but not poly(PA) proteins, are 
expressed in cells transfected with (CCCCgg)66. No c9rAN protein 
was detected in control cells expressing non-expanded (CCCCgg)2
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Fig. 4  C9ORF72 hexanu-
cleotide repeat transcripts 
form nuclear rNA foci in 
frontal cortex, spinal cord and 
cerebellum in c9FTD/AlS. 
Fluorescence in situ hybridiza-
tion (FISH) of c9FTD/AlS 
frontal cortex (a) and c9AlS 
spinal cord (b) tissue using a 
probe against the CCCCgg 
repeat transcripts shows rNA 
foci (red) in the nucleus (stained 
with DAPI, blue) of cells. In 
(b), note that foci are observed 
in motor neurons that stain posi-
tively for ChAT. c Cerebellar 
sections of c9FTD/AlS cases 
were subjected to FISH using a 
probe against CCCCgg repeat 
transcripts or ggggCC repeat 
transcripts. In most instances, 
foci-bearing cells within the 
cerebellum were found in 
proximity to the Purkinje cell 
layer separating the molecular 
and granular layers. However, 
rNA foci were also observed 
in cells of the molecular layer, 
deep within the granular layer, 
in Purkinje cells, and in cells 
within the white matter. Scale 
bars 10 μm
838 Acta Neuropathol (2013) 126:829–844
1 3
whether they had foci, and examined an additional 25 cells 
with foci and determined whether they had inclusions. 
Shown in Fig. 7c is the percentage of affected cells that had 
both foci and inclusions. Note that the brain region sam-
pled (frontal cortex vs. cerebellum) and foci type (antisense 
vs. sense) both significantly affect the percentage of cells 
having both foci and inclusions, as assessed by two-way 
ANOVA (Fig. 7c). The apparent increase in the percentage 
of cells having both inclusions and sense foci, compared to 
the percentage of cells having both inclusions and antisense 
foci, is not likely caused by increased frequency of sense 
foci. In the frontal cortex, where the difference between 
sense and antisense foci co-occurring with poly(gP)-inclu-
sions is most pronounced, there was no difference in the 
percentage of cells with sense or antisense foci in the cases 
examined (Fig. 7d).
Discussion
The discovery of new neuropathologic features specific 
to c9FTD/AlS, namely the formation of rNA foci and 
the production of c9rAN proteins resulting from the syn-
thesis of antisense transcripts of the expanded C9ORF72 
repeat, provides additional insight into the pathobiology 
of c9FTD/AlS. Through the production of both sense and 
antisense expanded repeat rNA and five distinct c9rAN 
proteins, the repeat expansion leads to the production of 
seven potentially toxic biomolecules.
To determine whether antisense transcripts of the 
expanded C9ORF72 repeat are rAN translated, we gen-
erated novel rabbit polyclonal antibodies for the detection 
of poly(gP), poly(Pr) and poly(PA) proteins. examina-
tion of rAN translation in cultured cell models showed 
that poly(gP) and poly(Pr) proteins were synthesized in 
(CCCCgg)66-expressing cells, but not in cells expressing 
only two CCCCgg repeats. That poly(PA) proteins were 
not detected in (CCCCgg)66-expressing cells may be 
because a crucial upstream sequence necessary for transla-
tion of poly(PA) peptides is missing from the (CCCCgg)66 
expression vector. Alternatively, it may be due to the fact 
that rAN translation is repeat length-dependent, with dif-
ferent reading frames having different length thresholds 
[9, 39]. Nonetheless, our immunohistochemical analysis 
of c9rAN proteins in human tissue indicates either this 
sequence is present, or the repeat length threshold is met, in 
c9FTD/AlS patients.
Because poly(gP) proteins can be synthesized from 
sense and antisense transcripts of the expanded C9ORF72 
repeat, their exact origin is not definitely known. Yet, the 
presence of poly(PA) and poly(Pr) neuronal inclusions in 
post-mortem c9FTD/AlS brain tissue is indicative of rAN 
translation of the antisense transcript. These inclusions are 
specific to c9FTD/AlS cases, not being found in matched 
FTD/AlS controls lacking the C9ORF72 expanded repeat, 
or in other repeat disorders. We did note a difference 
between poly(PA) and poly(Pr) pathology in comparison 
to poly(gP) pathology, the latter being markedly more fre-
quent. For example, poly(gP) pathology is extensive in 
granule cells and primary neurons of the cerebellum, but 
cerebellar poly(PA) and poly(Pr) inclusions are sparse in 
these same populations.
While we cannot rule-out the possibility that poly(gP) 
inclusions appear more abundant because of differences 
Fig. 5  Nuclear rNA foci are present in both neurons and glia. Fluo-
rescence in situ hybridization of c9FTD/AlS cerebellar tissue using 
a probe against the ggggCC repeat was followed by immunofluo-
rescence staining with the neuronal marker, MAP2, or the astrocytic 
marker, gFAP. Note that nuclear rNA foci are present in MAP2-pos-
itive and MAP2-negative cells, as well as gFAP-positive and gFAP-
negative cells. Scale bar 10 μm
Fig. 6  Antisense c9rAN proteins in human post-mortem tissue. 
Immunohistochemistry reveals poly(PA)- [left column], poly(Pr)- 
[middle column], and poly(gP)- [right column] reactive lesions 
throughout the central nervous system, including the hippocampus 
(endplate-CA3 on the top left, dentate fascia on the bottom right), cer-
ebellum, amygdala, thalamus, motor cortex (layers 2–3), and medulla 
(inferior olivary nucleus). lesions are often neuronal cytoplasmic 
inclusions (NCI) with a star-shaped morphology, but can also appear 
as dense NCI, small neuronal intranuclear inclusions, or diffuse neu-
ronal “pre-inclusions”. Anti-gP, which detects poly(gP) proteins 
that can be made from both sense and antisense transcripts of the 
C9ORF72 expanded repeat, reveal greater pathologic burden com-
pared to the anti-PA and Pr antibodies. Case numbers correspond to 
c9FTD/AlS cases in Table 1. Scale bar 10 μm
▸
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in antibody affinities, their increased frequency may be 
due to the fact that poly(gP) proteins are synthesized from 
both sense and antisense transcripts. In addition, the anti-
sense transcript may be less efficiently translated than the 
sense transcript. CCCCgg repeats are predicted to fold 
into an imperfect hairpin akin to what we have previously 
shown for ggggCC repeats [3]. However, compared 
to the ggggCC repeat, which has an optimal organiza-
tion to maximize base pairing, the CCCCgg repeat has 
fewer base pairs and more frequent sets of four unpaired 
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C nucleotides within the stem, and thus relies more on 
base stacking effects. While the stability of both CCCCgg 
and ggggCC repeat transcripts increases with increasing 
repeat length, the CCCCgg repeat is predicted to be less 
stable than its ggggCC counterpart, which may decrease 
its susceptibility to rAN translation. It should be men-
tioned that two previous studies report that r(ggggCC) 
repeats form an intramolecular g-quadraplex structure [13, 
29]. As has been suggested for other quadruplexes [8] and 
r(Cgg) repeats, the r(ggggCC) repeat, and perhaps the 
r(CCCCgg) repeat, may adopt two conformations that 
are in equilibrium: an extended hairpin structure and a 
quadruplex.
Another possible explanation for the higher frequency 
of poly(gP) inclusions in c9FTD/AlS may be due to 
ATg-initiated translation. While no sequence has been 
reported for the antisense transcript, resorting to analysis 
of the genomic DNA consensus sequence for C9ORF72 
has revealed no ATg codons for sense transcript-derived 
c9rAN proteins, or for the antisense transcript-derived 
poly(PA) protein. However, one and three potential ATg 
start codons were found in the antisense poly(Pr) and 
poly(gP) frames, respectively (Online resource 1). None-
theless, whether ATg codons are in fact present in rNA 
transcripts is not yet known, and our cell culture data pro-
vide evidence that poly(Pr) and poly(gP) proteins can be 
translated from (CCCCgg)exp in the absence of an ATg 
initiation site.
Whether aberrant expression of c9rAN proteins, 
and the inclusions formed thereof, influence disease 
pathogenesis remains to be elucidated. Nevertheless, the 
formation of abnormal proteinaceous inclusions is associ-
ated with neurotoxicity in various neurodegenerative dis-
eases. The inclusions may sequester other proteins causing 
loss of function, impair/overwhelm protein degradation 
systems, displace cytoplasmic organelles, and may them-
selves have neurotoxic properties. It is noteworthy that 
polyA and polyg proteins synthesized by rAN translation 
of expanded CAg·CTg repeats accumulate in disease-rel-
evant tissues of patients with spinocerebellar ataxia type 
8 and DM1, and that their expression in cultured cells is 
sufficient to cause apoptotic cell death [26]. In addition, 
in both DM1 patients and in mice expressing (CUg)exp, 
polyg aggregates co-localize with caspase-8, an early indi-
cator of polyg-induced apoptosis [26]. In c9FTD/AlS, 
neuronal inclusions of c9rAN proteins are similarly pre-
sent in vulnerable areas (e.g., neurons of neocortex and 
hippocampus), but there is a paucity of such inclusions in 
certain affected areas, such as the spinal cord [3, 25]. As 
with other aggregation-prone proteins involved in neuro-
degeneration (e.g., tau [14]), it remains unclear whether 
c9rAN inclusions per se are toxic, or whether rAN trans-
lation of transcripts from the C9ORF72 repeat contributes 
to neurodegeneration through the formation of toxic, solu-
ble oligomers.
As with rAN translation, the consequence of foci for-
mation in c9FTD/AlS is currently under investigation. 
Taking cues from other repeat expansion disorders, it is 
anticipated that foci will sequester select rNA-binding pro-
teins, and cause the misregulation of crucial downstream 
rNA targets. To date, studies have identified several pro-
teins that bind ggggCC transcripts [24, 29, 38]. The find-
ings herein highlight the necessity to similarly identify pro-
teins bound and sequestered by CCCCgg foci.
examination of foci formed of sense or antisense tran-
scripts of the expanded C9ORF72 repeat revealed that, in 
addition to the frontal cortex and spinal cord, rNA foci 
accumulate in the cerebellum. Together with other stud-
ies, it is now evident that numerous pathological features 
are present in the cerebellum of c9FTD/AlS patients, 
including nuclear rNA foci, c9rAN protein inclusions, 
as well as p62-positive inclusions [1, 3, 6, 25, 26]. Fur-
thermore, FTD cases caused by the C9ORF72 repeat 
expansion show atrophy of the parietal lobe and cerebel-
lum, in addition to frontal and temporal lobe atrophy 
[37]. In fact, c9FTD is characterized by greater cerebel-
lar atrophy than sporadic FTD, as well as FTD caused 
by mutations in MAPT [37]. Consequently, cerebellar 
atrophy, nuclear rNA foci, and proteinaceous inclusions 
may be considered characteristic features of c9FTD/AlS. 
Future studies of c9FTD/AlS should therefore encom-
pass evaluations of the cerebellum which, to date, has 
been largely neglected.
Fig. 7  Nuclear rNA foci and poly(gP) inclusions are seldom 
observed in the same cell. Fluorescence in situ hybridization of 
frontal cortex and cerebellar tissue of c9FTD/AlS cases using a 
probe against sense and antisense C9ORF72 hexanucleotide repeat 
transcripts was followed by immunofluorescence staining to detect 
poly(gP) inclusions, which may result from rAN translation of both 
sense and antisense transcripts. Though infrequent, both foci and 
poly(gP) inclusions can co-occur in the same cell (cells indicated 
by an asterisk in a and b). Scale bars 10 μm. AS antisense foci, S 
sense foci. c To determine the percentage of cells having both foci 
and poly(gP) inclusions in the frontal cortex and cerebellum, quanti-
tative analysis was undertaken on four cases co-stained for poly(gP) 
inclusions and either sense or antisense foci. For each section, we 
examined 25 cells with inclusions and determined whether they had 
foci, and examined 25 cells with foci and determined whether they 
had inclusions, for a total of 50 cells per section. Data are presented 
as mean ± SeM, n = 4. The brain region sampled (frontal cor-
tex vs. cerebellum, P = 0.0292) and foci type (antisense vs. sense, 
P = 0.0011) both significantly affect the percentage of cells having 
foci and inclusions, as assessed by two-way ANOVA. To determine 
the percentage of cells with antisense and sense foci in the frontal 
cortex, the number of cells with foci and the total number of cells 
were counted in 12 randomly selected, non-overlapping fields for 
each case. Data are presented as mean ± SeM, n = 4. No significant 
difference between the percentage of cells with sense or antisense 
foci was detected, as assessed by paired two-tailed t test (P = 0.1916) 
(d). n.s. not significant
◂
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Of interest, foci and poly(gP) inclusions were seldom 
observed in the same cell in the frontal cortex and cerebel-
lum of c9FTD/AlS patients. Although it is possible that 
foci too small to be easily detected are present in cells with 
poly(gP) inclusions, our findings suggest that only those 
(ggggCC)exp or (CCCCgg)exp transcripts that escape 
being sequestered as foci, and are instead exported to the 
cytoplasm, become available for rAN translation. That 
rNA foci are found in both neuronal and glial cells (Figs. 
4, 5), while poly(gP) inclusions are neuronal [3], coupled 
with the fact that rNA foci in the cerebellum are found in 
greatest abundance in cells in proximity to the Purkinje cell 
layer, whereas poly(gP) inclusions are widely expressed 
throughout the molecular and granule layers, does provide 
a basis for the lack of co-occurrence of these two features 
in a given cell. While it remains to be determined whether 
other c9rAN proteins are more frequently found in the 
same cells as foci, and whether both sense and antisense 
foci are present within the same cell, these findings support 
the notion that foci and inclusions represent two distinct 
pathogenic mechanisms for C9ORF72 repeat expansions.
Since the 2011 discovery that the expanded hexanu-
cleotide repeat in C9ORF72 causes chromosome 9p-linked 
FTD and AlS [11, 30], several neuropathological features 
unique to c9FTD/AlS have been identified [1, 3, 5, 7, 11, 
24, 25, 28]. The findings from the present study expand 
this list and highlight the need to broaden our view of 
potential disease mechanisms to include toxicity potential 
stemming from the antisense transcript. going forward, it 
will be critical to distinguish if and how rNA transcripts 
and c9rAN proteins contribute to the pathogenesis of dis-
ease, and whether the frequency or regional localization 
of rNA foci and c9rAN inclusions correlate with distinct 
clinical features. While these questions are being investi-
gated, c9rAN proteins should be explored as a biomarker 
for c9FTD/AlS, as should treatment strategies aimed at 
eradicating the putatively toxic sense and antisense tran-
scripts responsible for both foci formation and rAN 
translation.
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